IL17A and breast carcinoma: The aim of this study was to measure the serum IL-17A concentration in early invasive breast cancer patients before surgery and during adjuvant treatment and compare it to healthy controls, as well as to determine if there is a connection between the serum IL-17A concentration and the expression of IL-17A in the breast cancer tumor tissue.